Company: Temisis Therapeutics
Job title: Chief Scientific Officer
With a PhD in cell and molecular biology, Dr. Jean-François Ginglinger has worked as a scientist at the CNRS in Strasbourg for 6 years elucidating metabolic pathways and studying the catalytic activity of enzymes and their role in the cell and in ecology. He joined PAT in 2013 as Global R&D Partnerships Manager as well as Pharmaceutical API Development Manager. During his missions, he succeeded at establishing public-private consortiums, and led the development of pharmaceutical drug candidates in neurology and anti-inflammation. He is since October 2018 CSO of Temisis.
Small Pharma/Biotech Spotlight: Evaluate Overarching Challenges & Opportunities within the Dermatology Drug Development Landscape 2:30 pm
• Overcoming challenges and understanding opportunities of a small biotech in the field of dermatology • How can topical development help you accelerate your drug development strategy and gain value? • Optimising the development stage of your topical and oral assets towards clinicals trials • How does regulating the target NFKBIZ/IκBζ result in very high…Read more
day: Day One